CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment.
Li J, Huang T, Hua J, Wang Q, Su Y, Chen P, Bidlingmaier S, Li A, Xie Z, Bidkar AP, Shen S, Shi W, Seo Y, Flavell RR, Gioeli D, Dreicer R, Li H, Liu B, He J.
Li J, et al. Among authors: huang t.
J Exp Clin Cancer Res. 2023 Mar 11;42(1):61. doi: 10.1186/s13046-023-02636-x.
J Exp Clin Cancer Res. 2023.
PMID: 36906664
Free PMC article.